The Journey to Next-Generation ADCs: LCB’s Platform, Pipeline & What’s Next
- Overview of LCB's ConjuAll™ platform, the technology powering next-generation ADCs
- Highlighting updates on LCB's key drugs in clinical development
- Preclinical efficacy of newly clinical-stage candidates shaping LCB's future pipeline